And to assist medical professionals in the diagnosis and management of CAD,
AMI, Myocardial Oxygen demand/supply parity, global myocardial blood
flow deficiency. Many of the 20 million and more chest pain patients
reporting to hospital emergency rooms each year cannot be diagnosed
with standard non-invasive methodologies and would benefit from one
of a series of imaging procedures to diagnose or rule out CAD, AMI
etc. Early and accurate diagnosis of these patients will enable the
appropriate administration of therapeutic solutions, but will also
assure more appropriate use of health care resources. Beyond its
value as a diagnostic tool, HaemoSeis-256 can provide essential
information during treatment and recovery processes.
Mass Evaluation
Risk Stratification
Ischemia
Evaluation
Control of therapeutic drugs
Accurate
differential diagnosis of acute chest pain
Evaluation
of PTCA, stent implantation, CABG
Neonatal
circulatory status and neonatal circulatory adaptation
Pre-operative patient
evaluation in non-cardiac surgeries
Optimal
programming of pacemakers
Forecast signals & early
detection of pulmonary edema and LV failure
Establishment
of fluid overloads during dialysis and plasmapheresis
Post
AMI, PTCA and CABG rehabilitation
Assess
global myocardial blood flow after PTCA and CABG
To assess the ANS predominance
